On July 13th, 2012, the Asian-Pacific Regional Sales Manager from Itamar, an Israel Company, visited the headquarters of Angy (China) Medical Limited, which is located in Guangzhou. Angy’s General Manager and the director and manager from Product Developing Department received this distinguished guest at the conference room and extended a warm welcome for her coming.
Itamar is a public company. Its proprietary product EndoPAT is the only FDA cleared device for assessing endothelial function non-invasively in the world and its sales network has spread to Europe, America and Asia. During the meeting, the sales manager from Itamar introduced in detail the importance of assessing endothelial function and the clinical applications of EndoPAT. At the same time, Angy’s general manager introduced our current sales scale, standardized management and the strategy for further development etc. to showAngy’s capability and strength, and expressed our sincerity for cooperation. At last, both parties held a comprehensive discussion on the strategy for EndoPAT’s development in China as well as the cooperative terms. Both parties finally reached a preliminary consensus.
At the end of the meeting, both parties expressed their expectation for further cooperation. We sincerely hope that through a further negotiation, Angy will bring in a new high-tech medical device in the near future.
